BIOFRONTERA AG

B8F
Delayed Xetra - 11:36 2022-11-29 am EST
1.590 EUR +0.32%

Turn to zoom
Prev.1.59000000
Open1.61000000
High1.61000000
Low1.56500000
Volume4 572
Latest news
6d ago
6d ago
11/14
10/31
Chart BIOFRONTERA AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance1,641,721,68
Spread/Res.-3,0%-7,3%-5,1%
Spread/Supp.1,3%20%20%
Support1,571,331,33
Financials
Sales 2022 26,2 M 27,1 M 27,1 M
Net income 2022 -38,1 M -39,4 M -39,4 M
Net Debt 2022 - - -
P/E ratio 2022 -2,65x
Yield 2022 -
Capitalization 90,2 M 93,2 M 93,2 M
Capi. / Sales 2022 3,44x
Capi. / Sales 2023 2,96x
Nbr of Employees 102
Free-Float 49,7%
Company
Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for...
Sector :
Biopharmaceuticals
Calendar :
2023-04-11 Earnings Release
Trading Rating : -
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,59 €
Average target price 2,80 €
Spread / Average Target 76,1%